The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial
SOLID-TIMI 52
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
1 other identifier
interventional
13,026
36 countries
914
Brief Summary
This study will test whether darapladib can safely lower the chances of having a cardiovascular event (such as a heart attack or urgent coronary revascularization (e.g. medical procedures performed to restore the normal blood flow in patients with atherosclerosis)) when treatment is started within 30 days after an acute coronary syndrome (also called ACS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Dec 2009
Typical duration for phase_3
914 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2009
CompletedFirst Posted
Study publicly available on registry
October 23, 2009
CompletedStudy Start
First participant enrolled
December 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 24, 2014
CompletedResults Posted
Study results publicly available
August 10, 2017
CompletedAugust 10, 2017
June 1, 2017
4.3 years
October 22, 2009
June 9, 2017
July 12, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With First Occurrence of Any Event in the Composite of Major Coronary Events During the Time Period for Follow-up (FU) of Cardiovascular (CV) Event
Coronary heart disease (CHD) death=occurrence of a fatal myocardial infarction (MI), death caused by documented cardiac arrest, death resulting from heart failure in a participant with known CHD, death from other forms of acute/chronic CHD, unwitnessed death of unknown origin, or sudden death. Acute MI=evidence of myocardial necrosis in a clinical setting consistent with myocardial ischemia. Prior MI diagnosed post-randomization (e.g., silent MI)=the development of new pathological Q waves with/without symptoms OR imaging evidence of a region of loss of viable myocardium that is thinned and fails to contract, in the absence of a nonischemic cause (pre-event imaging data required for verification of new abnormality), OR pathological findings of a healed/healing MI. Urgent coronary revascularization (CR) for MI=ischemic discomfort at rest that prompted CR during the same hospitalization or resulted in hospital transfer for the purpose of CR.
From randomization until the End-of-Treatment visit or the last date on which endpoints were able to be assessed (up to 3.80 years)
Secondary Outcomes (11)
Number of Participants With First Occurrence of Any Component of the Composite of Major Adverse Cardiovascular Events (Cardiovascular [CV] Death, Non-fatal MI or Non-fatal Stroke) During the Time Period for Follow-up of CV Events
From randomization until the End-of-Treatment visit or the last date on which endpoints were able to be assessed (up to 3.80 years)
Number of Participants With Cardiovascular Death During the Time Period for Follow-up of Cardiovascular Events
From randomization until the End-of-Treatment visit or the last date on which endpoints were able to be assessed (up to 3.80 years)
Number of Participants With First Occurrence of MI (Fatal/Nonfatal) During the Time Period for Follow-up of Cardiovascular Events
From randomization until the End-of-Treatment visit or the last date on which endpoints were able to be assessed (up to 3.80 years)
Number of Participants With First Occurrence of Stroke (Fatal/Non-fatal) During the Time Period for Follow-up of Cardiovascular Events
From randomization until the End-of-Treatment visit or the last date on which endpoints were able to be assessed (up to 3.80 years)
Number of Participants With CHD Death During the Time Period for Follow-up of Cardiovascular Events
From randomization until the End-of-Treatment visit or the last date on which endpoints were able to be assessed (up to 3.80 years)
- +6 more secondary outcomes
Study Arms (2)
Darapladib 160 mg
EXPERIMENTALSingle daily oral tablet
Placebo
PLACEBO COMPARATORSingle daily oral tablet
Interventions
Eligibility Criteria
You may qualify if:
- Signed written informed consent.
- Men or women at least 18 years old (in Taiwan, at least 20 years old). Women must be post-menopausal or using a highly effective method for avoidance of pregnancy.
- Hospitalization for acute coronary syndrome (ACS) within 30 days prior to study entry.
- Clinically stable for 24 hours prior to study entry.
- A planned percutaneous coronary intervention (PCI) should be performed prior to study entry, whenever possible.
- At least one of the following:
- At least 60 years old.
- Myocardial infarction prior to the qualifying ACS event.
- Diabetes mellitus requiring treatment with medication.
- Diagnosed mild or moderate reduction in kidney function.
- Cerebrovascular disease (carotid artery disease or ischemic stroke more than 3 months prior to study entry) OR peripheral artery disease.
You may not qualify if:
- ACS symptoms or lab results not believed to be caused by a narrowing or blocked coronary artery.
- No major coronary artery with a blockage of more than 50% (unless all stenoses are successfully treated by PCI).
- Planned coronary artery bypass graft (CABG) surgery, or CABG surgery performed after the qualifying ACS event and prior to study entry.
- Certain types of liver disease.
- Severe reduction in kidney function OR removal of a kidney OR kidney transplant.
- Severe heart failure.
- Blood pressure higher than normal despite lifestyle changes and treatment with medications.
- Any life-threatening disease with a life expectancy of less than 2 years (other than heart disease) that may prevent the subject from completing the study.
- Severe asthma that is poorly controlled with medication.
- Pregnancy (Note: A pregnancy test will be performed on all non-sterile women prior to study entry).
- Previous severe allergic reaction to food, medications, drink, insect stings, etc.
- Drug or alcohol abuse within the past 6 months. Mental/psychological impairment that may prevent the subject from complying with study procedures or understanding the goal and potential risks of participating in the study.
- Certain medications that may interfere with the study medication (these will be identified by the study doctor).
- If both birth parents are at least 50% Japanese, Chinese, or Korean ancestry, must have a blood sample collected for Lp-PLA2 activity. Those with Lp-PLA2 activity less than or equal to 20.0 nmol/min/mL are excluded.
- Previously took darapladib (SB-480848).
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GlaxoSmithKlinelead
- The TIMI Study Groupcollaborator
Study Sites (914)
GSK Investigational Site
Birmingham, Alabama, 35243, United States
GSK Investigational Site
Birmingham, Alabama, 35294, United States
GSK Investigational Site
Huntsville, Alabama, 35801, United States
GSK Investigational Site
Mobile, Alabama, 36604, United States
GSK Investigational Site
Mobile, Alabama, 36608, United States
GSK Investigational Site
Anchorage, Alaska, 99508, United States
GSK Investigational Site
Cottonwood, Arizona, 86326, United States
GSK Investigational Site
Glendale, Arizona, 85306, United States
GSK Investigational Site
Tucson, Arizona, 85710, United States
GSK Investigational Site
Tucson, Arizona, 85723, United States
GSK Investigational Site
Tucson, Arizona, 85724, United States
GSK Investigational Site
Fort Smith, Arkansas, 72903, United States
GSK Investigational Site
Jonesboro, Arkansas, 72401, United States
GSK Investigational Site
Little Rock, Arkansas, 72205, United States
GSK Investigational Site
Bakersfield, California, 93308, United States
GSK Investigational Site
Bakersfield, California, 93309, United States
GSK Investigational Site
Beverly Hills, California, 90211, United States
GSK Investigational Site
Fresno, California, 93721, United States
GSK Investigational Site
Glendale, California, 91204, United States
GSK Investigational Site
La Mesa, California, 91942, United States
GSK Investigational Site
Lomita, California, 90717, United States
GSK Investigational Site
Los Alamitos, California, 90720, United States
GSK Investigational Site
Los Angeles, California, 90015, United States
GSK Investigational Site
Los Angeles, California, 90073, United States
GSK Investigational Site
Mission Hills, California, 91345, United States
GSK Investigational Site
Roseville, California, 95661, United States
GSK Investigational Site
Sacramento, California, 95819, United States
GSK Investigational Site
San Diego, California, 92161, United States
GSK Investigational Site
Santa Ana, California, 92704, United States
GSK Investigational Site
Santa Ana, California, 92705, United States
GSK Investigational Site
Stockton, California, 95204, United States
GSK Investigational Site
Thousand Oaks, California, 91360, United States
GSK Investigational Site
Torrance, California, 90509, United States
GSK Investigational Site
Ventura, California, 93003, United States
GSK Investigational Site
Colorado Springs, Colorado, 80920, United States
GSK Investigational Site
Golden, Colorado, 80401, United States
GSK Investigational Site
Greeley, Colorado, 80631, United States
GSK Investigational Site
Littleton, Colorado, 80120, United States
GSK Investigational Site
Wheat Ridge, Colorado, 80033, United States
GSK Investigational Site
Bridgeport, Connecticut, 06606, United States
GSK Investigational Site
Bridgeport, Connecticut, 06610, United States
GSK Investigational Site
Guilford, Connecticut, 06437, United States
GSK Investigational Site
Hartford, Connecticut, 06067, United States
GSK Investigational Site
Atlantis, Florida, 33462, United States
GSK Investigational Site
Aventura, Florida, 33180, United States
GSK Investigational Site
Brandon, Florida, 33511, United States
GSK Investigational Site
Clearwater, Florida, 33756, United States
GSK Investigational Site
Daytona Beach, Florida, 32114, United States
GSK Investigational Site
Daytona Beach, Florida, 32117, United States
GSK Investigational Site
Fleming Island, Florida, 32003, United States
GSK Investigational Site
Fort Lauderdale, Florida, 33316, United States
GSK Investigational Site
Gainesville, Florida, 32610, United States
GSK Investigational Site
Gulf Breeze, Florida, 32561, United States
GSK Investigational Site
Hollywood, Florida, 33021, United States
GSK Investigational Site
Inverness, Florida, 34452, United States
GSK Investigational Site
Jacksonville, Florida, 32207, United States
GSK Investigational Site
Jacksonville, Florida, 32209, United States
GSK Investigational Site
Jacksonville, Florida, 32216, United States
GSK Investigational Site
Jacksonville Beach, Florida, 32250, United States
GSK Investigational Site
Jupiter, Florida, 33458, United States
GSK Investigational Site
Kissimmee, Florida, 34741, United States
GSK Investigational Site
Miramar, Florida, 33025, United States
GSK Investigational Site
Ocala, Florida, 34471, United States
GSK Investigational Site
Palm Beach Gardens, Florida, 33410, United States
GSK Investigational Site
Pensacola, Florida, 32501, United States
GSK Investigational Site
Plantation, Florida, 33317, United States
GSK Investigational Site
Port Charlotte, Florida, 33952, United States
GSK Investigational Site
Safety Harbor, Florida, 34695, United States
GSK Investigational Site
Sarasota, Florida, 34232, United States
GSK Investigational Site
St. Petersburg, Florida, 33713, United States
GSK Investigational Site
Tallahassee, Florida, 32308, United States
GSK Investigational Site
Trinity, Florida, 34655, United States
GSK Investigational Site
Vero Beach, Florida, 32960, United States
GSK Investigational Site
Wellington, Florida, 33449, United States
GSK Investigational Site
Atlanta, Georgia, 30342, United States
GSK Investigational Site
Augusta, Georgia, 30901, United States
GSK Investigational Site
Cumming, Georgia, 30041, United States
GSK Investigational Site
Boise, Idaho, 83712, United States
GSK Investigational Site
Aurora, Illinois, 60504, United States
GSK Investigational Site
Bannockburn, Illinois, 60015, United States
GSK Investigational Site
Chicago, Illinois, 60612, United States
GSK Investigational Site
Melrose Park, Illinois, 60160, United States
GSK Investigational Site
Mokena, Illinois, 60448, United States
GSK Investigational Site
North Chicago, Illinois, 60064, United States
GSK Investigational Site
Oakbrook Terrace, Illinois, 60181, United States
GSK Investigational Site
Park Ridge, Illinois, 60068, United States
GSK Investigational Site
Peoria, Illinois, 61614, United States
GSK Investigational Site
Rock Island, Illinois, 61201, United States
GSK Investigational Site
Avon, Indiana, 46123, United States
GSK Investigational Site
Fort Wayne, Indiana, 46804, United States
GSK Investigational Site
Hammond, Indiana, 46320, United States
GSK Investigational Site
Indianapolis, Indiana, 46237, United States
GSK Investigational Site
Indianapolis, Indiana, 46290, United States
GSK Investigational Site
Muncie, Indiana, 47303, United States
GSK Investigational Site
Munster, Indiana, 46321, United States
GSK Investigational Site
South Bend, Indiana, 46601-1066, United States
GSK Investigational Site
Valparaiso, Indiana, 46383, United States
GSK Investigational Site
Iowa City, Iowa, 52242, United States
GSK Investigational Site
West Des Moines, Iowa, 50266, United States
GSK Investigational Site
Crestview Hills, Kentucky, 41017, United States
GSK Investigational Site
Lexington, Kentucky, 40536-0294, United States
GSK Investigational Site
Louisville, Kentucky, 40205, United States
GSK Investigational Site
Louisville, Kentucky, 40207, United States
GSK Investigational Site
Alexandria, Louisiana, 71301, United States
GSK Investigational Site
Lafayette, Louisiana, 70506, United States
GSK Investigational Site
Lake Charles, Louisiana, 70601, United States
GSK Investigational Site
Shreveport, Louisiana, 71105, United States
GSK Investigational Site
Bangor, Maine, 04401, United States
GSK Investigational Site
Lewiston, Maine, 04240, United States
GSK Investigational Site
Scarborough, Maine, 04074, United States
GSK Investigational Site
Baltimore, Maryland, 21201, United States
GSK Investigational Site
Baltimore, Maryland, 21208, United States
GSK Investigational Site
Baltimore, Maryland, 21218, United States
GSK Investigational Site
Baltimore, Maryland, 21229, United States
GSK Investigational Site
Baltimore, Maryland, 21236, United States
GSK Investigational Site
Bel Air, Maryland, 21014, United States
GSK Investigational Site
Columbia, Maryland, 21044, United States
GSK Investigational Site
Salisbury, Maryland, 21801, United States
GSK Investigational Site
Towson, Maryland, 21204, United States
GSK Investigational Site
Ayer, Massachusetts, 01432, United States
GSK Investigational Site
Boston, Massachusetts, 02111, United States
GSK Investigational Site
Boston, Massachusetts, 02115, United States
GSK Investigational Site
Fall River, Massachusetts, 02720, United States
GSK Investigational Site
Springfield, Massachusetts, 01199, United States
GSK Investigational Site
Worcester, Massachusetts, 01655, United States
GSK Investigational Site
Ann Arbor, Michigan, 48109, United States
GSK Investigational Site
Dearborn, Michigan, 48124, United States
GSK Investigational Site
Detroit, Michigan, 48201, United States
GSK Investigational Site
Flint, Michigan, 48532, United States
GSK Investigational Site
Kalamazoo, Michigan, 49048, United States
GSK Investigational Site
Marquette, Michigan, 49855, United States
GSK Investigational Site
Pontiac, Michigan, 48341-2985, United States
GSK Investigational Site
Troy, Michigan, 48085, United States
GSK Investigational Site
Ypsilanti, Michigan, 48197, United States
GSK Investigational Site
Duluth, Minnesota, 55805, United States
GSK Investigational Site
Minneapolis, Minnesota, 55426, United States
GSK Investigational Site
Robbinsdale, Minnesota, 55422, United States
GSK Investigational Site
Saint Cloud, Minnesota, 56303, United States
GSK Investigational Site
Saint Paul, Minnesota, 55101, United States
GSK Investigational Site
Tupelo, Mississippi, 38801, United States
GSK Investigational Site
Columbia, Missouri, 65212, United States
GSK Investigational Site
Joplin, Missouri, 64804, United States
GSK Investigational Site
Kansas City, Missouri, 64114, United States
GSK Investigational Site
Springfield, Missouri, 65804, United States
GSK Investigational Site
St Louis, Missouri, 63110, United States
GSK Investigational Site
St Louis, Missouri, 63128, United States
GSK Investigational Site
Columbia Falls, Montana, 65201, United States
GSK Investigational Site
Great Falls, Montana, 59405, United States
GSK Investigational Site
Kalispell, Montana, 59901, United States
GSK Investigational Site
Grand Island, Nebraska, 68803, United States
GSK Investigational Site
Lincoln, Nebraska, 68526, United States
GSK Investigational Site
Omaha, Nebraska, 68131, United States
GSK Investigational Site
Papillion, Nebraska, 68046, United States
GSK Investigational Site
Las Vegas, Nevada, 89103, United States
GSK Investigational Site
Browns Mills, New Jersey, 08015, United States
GSK Investigational Site
Elizabeth, New Jersey, 07202, United States
GSK Investigational Site
Elmer, New Jersey, 8318, United States
GSK Investigational Site
Haddon Heights, New Jersey, 08035, United States
GSK Investigational Site
Linden, New Jersey, 07036, United States
GSK Investigational Site
Paterson, New Jersey, 07503, United States
GSK Investigational Site
Pomona, New Jersey, 8240, United States
GSK Investigational Site
Sewell, New Jersey, 08080, United States
GSK Investigational Site
Somerset, New Jersey, 08873, United States
GSK Investigational Site
Summit, New Jersey, 07902, United States
GSK Investigational Site
Voorhees Township, New Jersey, 08043, United States
GSK Investigational Site
West Orange, New Jersey, 07052, United States
GSK Investigational Site
Albuquerque, New Mexico, 87131-0001, United States
GSK Investigational Site
Albany, New York, 12211, United States
GSK Investigational Site
Brooklyn, New York, 11219, United States
GSK Investigational Site
Buffalo, New York, 14215, United States
GSK Investigational Site
New York, New York, 10001, United States
GSK Investigational Site
New York, New York, 10016, United States
GSK Investigational Site
New York, New York, 10021, United States
GSK Investigational Site
Peekskill, New York, 10567, United States
GSK Investigational Site
Roslyn, New York, 11576, United States
GSK Investigational Site
Stony Brook, New York, 11794, United States
GSK Investigational Site
Syracuse, New York, 13202, United States
GSK Investigational Site
The Bronx, New York, 10467, United States
GSK Investigational Site
Troy, New York, 12180, United States
GSK Investigational Site
Williamsville, New York, 14221, United States
GSK Investigational Site
Asheville, North Carolina, 28803, United States
GSK Investigational Site
Burlington, North Carolina, 27215, United States
GSK Investigational Site
Charlotte, North Carolina, 28204, United States
GSK Investigational Site
Concord, North Carolina, 28025, United States
GSK Investigational Site
Gastonia, North Carolina, 28054, United States
GSK Investigational Site
Greensboro, North Carolina, 27401, United States
GSK Investigational Site
Huntersville, North Carolina, 28078, United States
GSK Investigational Site
Matthews, North Carolina, 28105, United States
GSK Investigational Site
Monroe, North Carolina, 28112, United States
GSK Investigational Site
Pinehurst, North Carolina, 28374, United States
GSK Investigational Site
Raleigh, North Carolina, 27610, United States
GSK Investigational Site
Rocky Mount, North Carolina, 27804, United States
GSK Investigational Site
Salisbury, North Carolina, 28144, United States
GSK Investigational Site
Sanford, North Carolina, 27330, United States
GSK Investigational Site
Winston-Salem, North Carolina, 27157, United States
GSK Investigational Site
Grand Forks, North Dakota, 58201, United States
GSK Investigational Site
Canton, Ohio, 44718, United States
GSK Investigational Site
Cincinnati, Ohio, 45219, United States
GSK Investigational Site
Cincinnati, Ohio, 45267, United States
GSK Investigational Site
Cleveland, Ohio, 44106, United States
GSK Investigational Site
Dayton, Ohio, 45414, United States
GSK Investigational Site
Elyria, Ohio, 44035, United States
GSK Investigational Site
Fairfield, Ohio, 45014, United States
GSK Investigational Site
Fairview Park, Ohio, 44126, United States
GSK Investigational Site
Lorain, Ohio, 44053, United States
GSK Investigational Site
Mansfield, Ohio, 44906, United States
GSK Investigational Site
Middleburg Heights, Ohio, 44130, United States
GSK Investigational Site
Oakbrook Terrace, Ohio, 60181, United States
GSK Investigational Site
Sandusky, Ohio, 44870, United States
GSK Investigational Site
Toledo, Ohio, 43606, United States
GSK Investigational Site
Toledo, Ohio, 43614, United States
GSK Investigational Site
Youngstown, Ohio, 44501-1790, United States
GSK Investigational Site
Zanesville, Ohio, 43701, United States
GSK Investigational Site
Midwest City, Oklahoma, 73110, United States
GSK Investigational Site
Oklahoma City, Oklahoma, 73104, United States
GSK Investigational Site
Oklahoma City, Oklahoma, 73112, United States
GSK Investigational Site
Portland, Oregon, 97220, United States
GSK Investigational Site
Portland, Oregon, 97239, United States
GSK Investigational Site
Allentown, Pennsylvania, 18103, United States
GSK Investigational Site
Beaver, Pennsylvania, 15009, United States
GSK Investigational Site
Bethlehem, Pennsylvania, 18015, United States
GSK Investigational Site
Camp Hill, Pennsylvania, 17011, United States
GSK Investigational Site
Chambersburg, Pennsylvania, 17201, United States
GSK Investigational Site
Doylestown, Pennsylvania, 18901, United States
GSK Investigational Site
Erie, Pennsylvania, 16502, United States
GSK Investigational Site
Hershey, Pennsylvania, 17033, United States
GSK Investigational Site
Jenkintown, Pennsylvania, 19046, United States
GSK Investigational Site
Jersey Shore, Pennsylvania, 17740, United States
GSK Investigational Site
Lancaster, Pennsylvania, 17604, United States
GSK Investigational Site
Lansdale, Pennsylvania, 19446, United States
GSK Investigational Site
Leetsdale, Pennsylvania, 15056, United States
GSK Investigational Site
Philadelphia, Pennsylvania, 19141, United States
GSK Investigational Site
Pittsburgh, Pennsylvania, 15212, United States
GSK Investigational Site
Pittsburgh, Pennsylvania, 15240, United States
GSK Investigational Site
Sayre, Pennsylvania, 18840, United States
GSK Investigational Site
Scranton, Pennsylvania, 18501, United States
GSK Investigational Site
Sellersville, Pennsylvania, 18960, United States
GSK Investigational Site
West Chester, Pennsylvania, 19380, United States
GSK Investigational Site
York, Pennsylvania, 17405, United States
GSK Investigational Site
Charleston, South Carolina, 29401, United States
GSK Investigational Site
Charleston, South Carolina, 29425, United States
GSK Investigational Site
Columbia, South Carolina, 29204, United States
GSK Investigational Site
Greenville, South Carolina, 29607, United States
GSK Investigational Site
Rapid City, South Dakota, 57701, United States
GSK Investigational Site
Chattanooga, Tennessee, 37404, United States
GSK Investigational Site
Columbia, Tennessee, 38401, United States
GSK Investigational Site
Jackson, Tennessee, 38085, United States
GSK Investigational Site
Jackson, Tennessee, 38301, United States
GSK Investigational Site
Johnson City, Tennessee, 37604, United States
GSK Investigational Site
Nashville, Tennessee, 37205, United States
GSK Investigational Site
Oak Ridge, Tennessee, 37830, United States
GSK Investigational Site
Amarillo, Texas, 79106, United States
GSK Investigational Site
Austin, Texas, 78705, United States
GSK Investigational Site
Corpus Christi, Texas, 78404, United States
GSK Investigational Site
Dallas, Texas, 75226, United States
GSK Investigational Site
Dallas, Texas, 75390-8887, United States
GSK Investigational Site
Fort Worth, Texas, 76104, United States
GSK Investigational Site
Galveston, Texas, 77555-0553, United States
GSK Investigational Site
Harker Heights, Texas, 76548, United States
GSK Investigational Site
Houston, Texas, 77002, United States
GSK Investigational Site
Houston, Texas, 77030, United States
GSK Investigational Site
Houston, Texas, 77090, United States
GSK Investigational Site
Houston, Texas, 77124, United States
GSK Investigational Site
Katy, Texas, 77493, United States
GSK Investigational Site
Kingwood, Texas, 77339, United States
GSK Investigational Site
Round Rock, Texas, 78681, United States
GSK Investigational Site
San Antonio, Texas, 78229, United States
GSK Investigational Site
San Marcos, Texas, 78666, United States
GSK Investigational Site
Sugar Land, Texas, 77479, United States
GSK Investigational Site
Tyler, Texas, 75708, United States
GSK Investigational Site
Victoria, Texas, 77901, United States
GSK Investigational Site
Lynchburg, Virginia, 24501, United States
GSK Investigational Site
Midlothian, Virginia, 23114, United States
GSK Investigational Site
Richmond, Virginia, 23249, United States
GSK Investigational Site
Richmond, Virginia, 23294, United States
GSK Investigational Site
Richmond, Virginia, 23298, United States
GSK Investigational Site
Winchester, Virginia, 22601, United States
GSK Investigational Site
Bellevue, Washington, 98004, United States
GSK Investigational Site
Bellingham, Washington, 98225, United States
GSK Investigational Site
Burien, Washington, 98166, United States
GSK Investigational Site
Everett, Washington, 98201, United States
GSK Investigational Site
Kirkland, Washington, 98034, United States
GSK Investigational Site
Spokane, Washington, 99204-2334, United States
GSK Investigational Site
Spokane, Washington, 99204, United States
GSK Investigational Site
Tacoma, Washington, 98405, United States
GSK Investigational Site
Walla Walla, Washington, 99362, United States
GSK Investigational Site
Beloit, Wisconsin, 53511, United States
GSK Investigational Site
Green Bay, Wisconsin, 54301, United States
GSK Investigational Site
Madison, Wisconsin, 53713, United States
GSK Investigational Site
Wausau, Wisconsin, 54401, United States
GSK Investigational Site
Capital Federal, Buenos Aires, C1180AAX, Argentina
GSK Investigational Site
Ciudad Autonoma de Buenos Aires, Buenos Aires, C1179AAB, Argentina
GSK Investigational Site
Ciudad Autonoma de Buenos Aires, Buenos Aires, C1425AST, Argentina
GSK Investigational Site
Mar del Plata, Buenos Aires, B7600FZN, Argentina
GSK Investigational Site
Ramos Mejía, Buenos Aires, B1704ETD, Argentina
GSK Investigational Site
San Justo, Buenos Aires, B1754FPI, Argentina
GSK Investigational Site
San Nicolás de los Arroyos, Buenos Aires, B2900DMH, Argentina
GSK Investigational Site
Córdoba, Córdoba Province, X5000AAW, Argentina
GSK Investigational Site
Córdoba, Córdoba Province, X5000EPU, Argentina
GSK Investigational Site
Rosario, Santa Fe Province, 2002, Argentina
GSK Investigational Site
Rosario, Santa Fe Province, S2000BIF, Argentina
GSK Investigational Site
Rosario, Santa Fe Province, S2000CVD, Argentina
GSK Investigational Site
Rosario, Santa Fe Province, S2000ODA, Argentina
GSK Investigational Site
Rosario, Santa Fe Province, S2002OUR, Argentina
GSK Investigational Site
Buenos Aires, 1425, Argentina
GSK Investigational Site
Buenos Aires, C1181ACH, Argentina
GSK Investigational Site
Cipolletti, R8324CVM, Argentina
GSK Investigational Site
Corrientes, W3400AMZ, Argentina
GSK Investigational Site
Haedo, Buenos Aires, B1706AJU, Argentina
GSK Investigational Site
San Miguel de Tucumán, T4000ICL, Argentina
GSK Investigational Site
San Miguel de Tucumán, T4000IFL, Argentina
GSK Investigational Site
Santa Fe, 3000, Argentina
GSK Investigational Site
Sante Fe, S3000FSO, Argentina
GSK Investigational Site
Sante Fe, S3000GCI, Argentina
GSK Investigational Site
Zárate, B2800DGH, Argentina
GSK Investigational Site
Garran, Australian Capital Territory, 2606, Australia
GSK Investigational Site
Camperdown, New South Wales, 2050, Australia
GSK Investigational Site
Gosford, New South Wales, 2250, Australia
GSK Investigational Site
Auchenflower, Queensland, 4066, Australia
GSK Investigational Site
Herston, Queensland, 4029, Australia
GSK Investigational Site
Milton, Queensland, 4064, Australia
GSK Investigational Site
Adelaide, South Australia, 5000, Australia
GSK Investigational Site
Elizabeth Vale, South Australia, 5112, Australia
GSK Investigational Site
Hobart, Tasmania, 7000, Australia
GSK Investigational Site
Box Hill, Victoria, 3128, Australia
GSK Investigational Site
Nedlands, Victoria, 6009, Australia
GSK Investigational Site
Fremantle, Western Australia, 6160, Australia
GSK Investigational Site
Ashford, 5035, Australia
GSK Investigational Site
Aalst, 9300, Belgium
GSK Investigational Site
Bonheiden, 2820, Belgium
GSK Investigational Site
Brussels, 1000, Belgium
GSK Investigational Site
Brussels, 1090, Belgium
GSK Investigational Site
Brussels, 1200, Belgium
GSK Investigational Site
Edegem, 2650, Belgium
GSK Investigational Site
Genk, 3600, Belgium
GSK Investigational Site
La Louvière, 7100, Belgium
GSK Investigational Site
Leuven, 3000, Belgium
GSK Investigational Site
Liège, 4000, Belgium
GSK Investigational Site
Roeselaere, 8800, Belgium
GSK Investigational Site
Fortaleza, Ceará, 60864-190, Brazil
GSK Investigational Site
Salvador, Estado de Bahia, 41810010, Brazil
GSK Investigational Site
Goiânia - GO, Goiás, 74605-020, Brazil
GSK Investigational Site
Belo Horizonte, Minas Gerais, 30130-110, Brazil
GSK Investigational Site
Belo Horizonte, Minas Gerais, 30150-221., Brazil
GSK Investigational Site
Campina Grande do Sul, Paraná, 83430000, Brazil
GSK Investigational Site
Curitiba, Paraná, 80730-150, Brazil
GSK Investigational Site
Natal, Rio Grande do Norte, 59020-100, Brazil
GSK Investigational Site
Pelotas, Rio Grande do Sul, 96015-290, Brazil
GSK Investigational Site
Porto Alegre, Rio Grande do Sul, 90020-090, Brazil
GSK Investigational Site
Porto Alegre, Rio Grande do Sul, 90035-903, Brazil
GSK Investigational Site
Porto Alegre, Rio Grande do Sul, 90610000, Brazil
GSK Investigational Site
Porto Alegre, Rio Grande do Sul, 90620001, Brazil
GSK Investigational Site
Porto Alegre, Rio Grande do Sul, 90880-480, Brazil
GSK Investigational Site
Porto Alegre, Rio Grande do Sul, 91350-200, Brazil
GSK Investigational Site
Marília, São Paulo, 17515-000, Brazil
GSK Investigational Site
São José do Rio Preto, São Paulo, 15015210, Brazil
GSK Investigational Site
São José do Rio Preto, São Paulo, 15090-000, Brazil
GSK Investigational Site
São Paulo, São Paulo, 04024-900, Brazil
GSK Investigational Site
Votuporanga, São Paulo, 15500-003, Brazil
GSK Investigational Site
Bahia, 40050-410, Brazil
GSK Investigational Site
Brasília, 70658-700, Brazil
GSK Investigational Site
Campinas, 13060-803, Brazil
GSK Investigational Site
Campo Grande, 79080-090, Brazil
GSK Investigational Site
Rio de Janeiro, 21041-030, Brazil
GSK Investigational Site
Rio de Janeiro, RJ 22240-000, Brazil
GSK Investigational Site
São Paulo, 04012-180, Brazil
GSK Investigational Site
São Paulo, 05403000, Brazil
GSK Investigational Site
São Paulo, 05508-900, Brazil
GSK Investigational Site
São Paulo - SP, 01323-900, Brazil
GSK Investigational Site
Uberlândia, 38400-902, Brazil
GSK Investigational Site
Dimitrovgrad, 6400, Bulgaria
GSK Investigational Site
Haskovo, 6300, Bulgaria
GSK Investigational Site
Pleven, 5800, Bulgaria
GSK Investigational Site
Plovdiv, 4002, Bulgaria
GSK Investigational Site
Plovdiv, 4003, Bulgaria
GSK Investigational Site
Sofia, 1000, Bulgaria
GSK Investigational Site
Sofia, 1202, Bulgaria
GSK Investigational Site
Sofia, 1407, Bulgaria
GSK Investigational Site
Sofia, 1527, Bulgaria
GSK Investigational Site
Sofia, 1606, Bulgaria
GSK Investigational Site
Sofia, 1709, Bulgaria
GSK Investigational Site
Veliko Tarnovo, 5000, Bulgaria
GSK Investigational Site
Edmonton, Alberta, T6G 2B7, Canada
GSK Investigational Site
Campbell River, British Columbia, V9W 5Y4, Canada
GSK Investigational Site
New Westminster, British Columbia, V3L 3W4, Canada
GSK Investigational Site
Surrey, British Columbia, V3V 1N1, Canada
GSK Investigational Site
Vancouver, British Columbia, V5Z 1M9, Canada
GSK Investigational Site
Victoria, British Columbia, V8R 4R2, Canada
GSK Investigational Site
St. John's, Newfoundland and Labrador, A1B 3V6, Canada
GSK Investigational Site
Truro, Nova Scotia, B2N 1L2, Canada
GSK Investigational Site
Ajax, Ontario, L1S 7K8, Canada
GSK Investigational Site
Brampton, Ontario, L6Z 4N5, Canada
GSK Investigational Site
Cambridge, Ontario, N1R 6V6, Canada
GSK Investigational Site
Cambridge, Ontario, N1R 7R1, Canada
GSK Investigational Site
Greater Sudbury, Ontario, P3C 1S8, Canada
GSK Investigational Site
Greater Sudbury, Ontario, P3E 3B8, Canada
GSK Investigational Site
Hamilton, Ontario, L8L 2X2, Canada
GSK Investigational Site
Kelowna, Ontario, V1Y 1E4, Canada
GSK Investigational Site
Mississauga, Ontario, L5B 2P7, Canada
GSK Investigational Site
Newmarket, Ontario, L3Y 8C3, Canada
GSK Investigational Site
Oshawa, Ontario, L1J 2J9, Canada
GSK Investigational Site
Oshawa, Ontario, L1J 2K1, Canada
GSK Investigational Site
Ottawa, Ontario, K1Y 4W7, Canada
GSK Investigational Site
Sarnia, Ontario, N7T 4X3, Canada
GSK Investigational Site
Thunder Bay, Ontario, P7B 7C7, Canada
GSK Investigational Site
Toronto, Ontario, M4C 3E7, Canada
GSK Investigational Site
Toronto, Ontario, M5C 2T2, Canada
GSK Investigational Site
Greenfield Park, Quebec, JAV 2GB, Canada
GSK Investigational Site
Longueuil, Quebec, J4M 2X1, Canada
GSK Investigational Site
Montreal, Quebec, H1T 3Y7, Canada
GSK Investigational Site
Montreal, Quebec, H3G 1A4, Canada
GSK Investigational Site
Sherbrooke, Quebec, J1H 5N4, Canada
GSK Investigational Site
Thetford-Mines, Quebec, G6G 2V4, Canada
GSK Investigational Site
Temuco, Región de La Araucania, Chile
GSK Investigational Site
Viña del Mar, Región de Valparaíso, Chile
GSK Investigational Site
Concepción, Región Del Biobio, 56-41, Chile
GSK Investigational Site
Talcahuano, Región Del Biobio, 427 0918, Chile
GSK Investigational Site
Santiago, Región Metro de Santiago, 750 0922, Chile
GSK Investigational Site
Santiago, Región Metro de Santiago, 7650018, Chile
GSK Investigational Site
Santiago, Región Metro de Santiago, 8330024, Chile
GSK Investigational Site
Santiago, 8207257, Chile
GSK Investigational Site
Santiago, 8900085, Chile
GSK Investigational Site
Temuco, Chile
GSK Investigational Site
Lanzhou, Gansu, 730030, China
GSK Investigational Site
Guangzhou, Guangdong, 510080, China
GSK Investigational Site
Guangzhou, Guangdong, 510120, China
GSK Investigational Site
Nanning, Guangxi, 530021, China
GSK Investigational Site
Haikou, Hainan, 570102, China
GSK Investigational Site
Shijiazhuang, Hebei, 050000, China
GSK Investigational Site
Nanjing, Jiangsu, 210029, China
GSK Investigational Site
Dalian, Liaoning, 116027, China
GSK Investigational Site
Shenyang, Liaoning, 110004, China
GSK Investigational Site
Shenyang, Liaoning, 110016, China
GSK Investigational Site
Xi'an, Shaanxi, 710061, China
GSK Investigational Site
Jinan, Shandong, 250033, China
GSK Investigational Site
Chengdu, Sichuan, 610041, China
GSK Investigational Site
Hangzhou, Zhejiang, 310009, China
GSK Investigational Site
Beijing, 100020, China
GSK Investigational Site
Beijing, 100029, China
GSK Investigational Site
Beijing, 100037, China
GSK Investigational Site
Beijing, 100050, China
GSK Investigational Site
Beijing, 100730, China
GSK Investigational Site
Beijing, 100853, China
GSK Investigational Site
Hangzhou, 310016, China
GSK Investigational Site
Jinan, 250012, China
GSK Investigational Site
Shanghai, 200003, China
GSK Investigational Site
Shanghai, 200040, China
GSK Investigational Site
Shanghai, 200065, China
GSK Investigational Site
Suzhou, 215004, China
GSK Investigational Site
Armenia, Colombia
GSK Investigational Site
Barranquilla, Colombia
GSK Investigational Site
Bogotá, 38007, Colombia
GSK Investigational Site
Bogotá, 5600520, Colombia
GSK Investigational Site
Bogotá, Colombia
GSK Investigational Site
Bucaramanga, Colombia
GSK Investigational Site
Cartagena, Colombia
GSK Investigational Site
Manizales, Colombia
GSK Investigational Site
Medellín, Colombia
GSK Investigational Site
Brno, 625 00, Czechia
GSK Investigational Site
Brno, 656 91, Czechia
GSK Investigational Site
Čáslav, 286 01, Czechia
GSK Investigational Site
Jihlava, 586 33, Czechia
GSK Investigational Site
Kroměříž, 767 55, Czechia
GSK Investigational Site
Milevsko, 399 01, Czechia
GSK Investigational Site
Olomouc, 775 20, Czechia
GSK Investigational Site
Plzen - Bory, 305 99, Czechia
GSK Investigational Site
Prague, 100 34, Czechia
GSK Investigational Site
Prague, 128 08, Czechia
GSK Investigational Site
Slaný, Czechia
GSK Investigational Site
Svitavy, 568 25, Czechia
GSK Investigational Site
Ústí nad Orlicí, 562 18, Czechia
GSK Investigational Site
Zlín, 762 75, Czechia
GSK Investigational Site
Aalborg, DK-9000, Denmark
GSK Investigational Site
Aarhus, DK-8000, Denmark
GSK Investigational Site
Esbjerg, 6700, Denmark
GSK Investigational Site
Frederikssund, DK-3600, Denmark
GSK Investigational Site
Glostrup Municipality, DK-2600, Denmark
GSK Investigational Site
Hellerup, 2900, Denmark
GSK Investigational Site
Herlev, DK-2730, Denmark
GSK Investigational Site
Holbæk, DK-4300, Denmark
GSK Investigational Site
Hvidovre, DK-2650, Denmark
GSK Investigational Site
Koebenhavn N, 2100, Denmark
GSK Investigational Site
Kolding, DK-6000, Denmark
GSK Investigational Site
København NV, DK-2400, Denmark
GSK Investigational Site
København S, DK-2300, Denmark
GSK Investigational Site
Køge, DK-4600, Denmark
GSK Investigational Site
Næstved, 4700, Denmark
GSK Investigational Site
Odense C, DK-5000, Denmark
GSK Investigational Site
Roskilde, 4000, Denmark
GSK Investigational Site
Silkeborg, DK-8600, Denmark
GSK Investigational Site
Svendborg, 5700, Denmark
GSK Investigational Site
Pau, Aquitaine, 64046, France
GSK Investigational Site
Langres, Champagne-Ardenne, 52206, France
GSK Investigational Site
Dunkirk, Hauts-de-France, 59240, France
GSK Investigational Site
Avignon, 84000, France
GSK Investigational Site
Besançon, 25030, France
GSK Investigational Site
Bron, 69677, France
GSK Investigational Site
Créteil, 94010, France
GSK Investigational Site
Dijon, 21079, France
GSK Investigational Site
Lagny-sur-Marne, 77405, France
GSK Investigational Site
Le Plessis-Robinson, 92350, France
GSK Investigational Site
Lille, 59000, France
GSK Investigational Site
Marseille, 13285, France
GSK Investigational Site
Montfermeil, 93370, France
GSK Investigational Site
Paris, 75651, France
GSK Investigational Site
Paris, 75877, France
GSK Investigational Site
Poitiers, 86021, France
GSK Investigational Site
Quincy-sous-Sénart, 91480, France
GSK Investigational Site
Rennes, 35033, France
GSK Investigational Site
Strasbourg, 67091, France
GSK Investigational Site
Toulouse, 31500, France
GSK Investigational Site
Tourcoing, 59200, France
GSK Investigational Site
Valenciennes, 59300, France
GSK Investigational Site
Bad Krozingen, Baden-Wurttemberg, 79189, Germany
GSK Investigational Site
Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany
GSK Investigational Site
Heidelberg, Baden-Wurttemberg, 69120, Germany
GSK Investigational Site
Stuttgart, Baden-Wurttemberg, 70376, Germany
GSK Investigational Site
Ulm, Baden-Wurttemberg, 89081, Germany
GSK Investigational Site
Munich, Bavaria, 80336, Germany
GSK Investigational Site
Munich, Bavaria, 81737, Germany
GSK Investigational Site
Bad Nauheim, Hesse, 61231, Germany
GSK Investigational Site
Darmstadt, Hesse, 64283, Germany
GSK Investigational Site
Frankfurt am Main, Hesse, 60590, Germany
GSK Investigational Site
Frankfurt am Main, Hesse, 65929, Germany
GSK Investigational Site
Langen, Hesse, 63225, Germany
GSK Investigational Site
Limburg an der Lahn, Hesse, 65549, Germany
GSK Investigational Site
Bad Rothenfelde, Lower Saxony, 49214, Germany
GSK Investigational Site
Hanover, Lower Saxony, 30625, Germany
GSK Investigational Site
Oldenburg, Lower Saxony, 26133, Germany
GSK Investigational Site
Bielefeld, North Rhine-Westphalia, 33604, Germany
GSK Investigational Site
Eschweiler, North Rhine-Westphalia, 52249, Germany
GSK Investigational Site
Essen, North Rhine-Westphalia, 45122, Germany
GSK Investigational Site
Essen, North Rhine-Westphalia, 45359, Germany
GSK Investigational Site
Neuss, North Rhine-Westphalia, 41464, Germany
GSK Investigational Site
Wuppertal, North Rhine-Westphalia, 42117, Germany
GSK Investigational Site
Ludwigshafen am Rhein, Rhineland-Palatinate, 67063, Germany
GSK Investigational Site
Homburg, Saarland, 66421, Germany
GSK Investigational Site
Kiel, Schleswig-Holstein, 24105, Germany
GSK Investigational Site
Lübeck, Schleswig-Holstein, 23538, Germany
GSK Investigational Site
Altenburg, Thuringia, 04600, Germany
GSK Investigational Site
Berlin, 12351, Germany
GSK Investigational Site
Berlin, 12559, Germany
GSK Investigational Site
Berlin, 13353, Germany
GSK Investigational Site
Bremen, 28277, Germany
GSK Investigational Site
Halle, 06120, Germany
GSK Investigational Site
Hamburg, 20246, Germany
GSK Investigational Site
Budapest, 1032, Hungary
GSK Investigational Site
Budapest, 1096, Hungary
GSK Investigational Site
Budapest, 1106, Hungary
GSK Investigational Site
Budapest, 1122, Hungary
GSK Investigational Site
Budapest, 1125, Hungary
GSK Investigational Site
Budapest, 1134, Hungary
GSK Investigational Site
Budapest, 1145, Hungary
GSK Investigational Site
Cegléd, 2700, Hungary
GSK Investigational Site
Eger, 3300, Hungary
GSK Investigational Site
Gyula, 5700, Hungary
GSK Investigational Site
Hódmezővásárhely, 6800, Hungary
GSK Investigational Site
Kistarcsa, 2143, Hungary
GSK Investigational Site
Miskolc, 3526, Hungary
GSK Investigational Site
Székesfehérvár, 8000, Hungary
GSK Investigational Site
Szolnok, 5004, Hungary
GSK Investigational Site
Szombathely, 9700, Hungary
GSK Investigational Site
Zalaegerszeg, 8900, Hungary
GSK Investigational Site
Ahmedabad, 380052, India
GSK Investigational Site
Ahmedabad, 380060, India
GSK Investigational Site
Amritsar, 143004, India
GSK Investigational Site
Chennai, 600037, India
GSK Investigational Site
Chennai, 600081, India
GSK Investigational Site
Faridabad, 121001, India
GSK Investigational Site
Gandhinagar, 382428, India
GSK Investigational Site
Gūrgaon, 122001, India
GSK Investigational Site
Hyderabad, 500001, India
GSK Investigational Site
Hyderabad, 500020, India
GSK Investigational Site
Hyderabad, 500033, India
GSK Investigational Site
Hyderabad, 500063, India
GSK Investigational Site
Hyderabad, 500082, India
GSK Investigational Site
Indore, 452018, India
GSK Investigational Site
Jaipur, 302017, India
GSK Investigational Site
Lucknow, 226014, India
GSK Investigational Site
Mohali, 160062, India
GSK Investigational Site
New Delhi, 110025, India
GSK Investigational Site
New Delhi, 110060, India
GSK Investigational Site
New Delhi, 110070, India
GSK Investigational Site
Noida, 201301, India
GSK Investigational Site
Patiāla, 147001, India
GSK Investigational Site
Pune, 411001, India
GSK Investigational Site
Pune, 411004, India
GSK Investigational Site
Secunderabad, 500003, India
GSK Investigational Site
Vadodara, 390015, India
GSK Investigational Site
Visakhapatnam, 530002, India
GSK Investigational Site
Ashkelon, 78278, Israel
GSK Investigational Site
Beersheba, 84350, Israel
GSK Investigational Site
Haddera, 38100, Israel
GSK Investigational Site
Haifa, 31048, Israel
GSK Investigational Site
Haifa, 31096, Israel
GSK Investigational Site
Haifa, 34362, Israel
GSK Investigational Site
Holon, 58100, Israel
GSK Investigational Site
Jerusalem, 91004, Israel
GSK Investigational Site
Jerusalem, 91031, Israel
GSK Investigational Site
Jerusalem, 91120, Israel
GSK Investigational Site
Jerusalem, 91240, Israel
GSK Investigational Site
Kfar Saba, 44281, Israel
GSK Investigational Site
Nahariya, 22100, Israel
GSK Investigational Site
Poria – Neve Oved, 15208, Israel
GSK Investigational Site
Raanana, 43000, Israel
GSK Investigational Site
Ramat Gan, 52621, Israel
GSK Investigational Site
Rehovot, 76100, Israel
GSK Investigational Site
Safed, 13110, Israel
GSK Investigational Site
Tel Aviv, 64239, Israel
GSK Investigational Site
Catanzaro, Calabria, 88100, Italy
GSK Investigational Site
Napoli, Campania, 80131, Italy
GSK Investigational Site
Bologna, Emilia-Romagna, 40138, Italy
GSK Investigational Site
Carpi, Emilia-Romagna, 41012, Italy
GSK Investigational Site
Ferrara, Emilia-Romagna, 44100, Italy
GSK Investigational Site
Parma, Emilia-Romagna, 43100, Italy
GSK Investigational Site
Palmanova, Friuli Venezia Giulia, 33057, Italy
GSK Investigational Site
San Daniele del Friuli, Friuli Venezia Giulia, 33038, Italy
GSK Investigational Site
Udine, Friuli Venezia Giulia, 33100, Italy
GSK Investigational Site
Rome, Lazio, 00135, Italy
GSK Investigational Site
Rome, Lazio, 00168, Italy
GSK Investigational Site
Rome, Lazio, 00189, Italy
GSK Investigational Site
Bergamo, Lombardy, 24128, Italy
GSK Investigational Site
Milan, Lombardy, 20162, Italy
GSK Investigational Site
Rozzano (Mi), Lombardy, 20089, Italy
GSK Investigational Site
Novara, Piedmont, 28100, Italy
GSK Investigational Site
Sassari, Sardinia, 07100, Italy
GSK Investigational Site
Ascoli Piceno, The Marches, 63100, Italy
GSK Investigational Site
Pisa, Tuscany, 56126, Italy
GSK Investigational Site
Treviso, Veneto, 31100, Italy
GSK Investigational Site
Legnano, 20025, Italy
GSK Investigational Site
Sassuolo, 41049, Italy
GSK Investigational Site
Chiba, 270-2251, Japan
GSK Investigational Site
Fukuoka, 807-0051, Japan
GSK Investigational Site
Fukuoka, 811-0213, Japan
GSK Investigational Site
Fukuoka, 816-0864, Japan
GSK Investigational Site
Hokkaido, 006-8555, Japan
GSK Investigational Site
Hokkaido, 063-0005, Japan
GSK Investigational Site
Hokkaido, 065-0033, Japan
GSK Investigational Site
Hyōgo, 650-0047, Japan
GSK Investigational Site
Kanagawa, 232-0024, Japan
GSK Investigational Site
Kanagawa, 243-8551, Japan
GSK Investigational Site
Kanagawa, 247-8533, Japan
GSK Investigational Site
Kyoto, 606-8507, Japan
GSK Investigational Site
Nagasaki, 856-8562, Japan
GSK Investigational Site
Okayama, 700-8558, Japan
GSK Investigational Site
Osaka, 565-8565, Japan
GSK Investigational Site
Osaka, 574-0074, Japan
GSK Investigational Site
Osaka, 580-0032, Japan
GSK Investigational Site
Ōita, 870-0263, Japan
GSK Investigational Site
Saga, 843-0393, Japan
GSK Investigational Site
Shizuoka, 410-2295, Japan
GSK Investigational Site
Tokyo, 101-8643, Japan
GSK Investigational Site
Tokyo, 113-8431, Japan
GSK Investigational Site
Tokyo, 160-8582, Japan
GSK Investigational Site
Tokyo, 196-0003, Japan
GSK Investigational Site
's-Hertogenbosch, 5223 GZ, Netherlands
GSK Investigational Site
Amersfoort, 3818 ES, Netherlands
GSK Investigational Site
Amsterdam, 1061 AE, Netherlands
GSK Investigational Site
Amsterdam, 1091 AC, Netherlands
GSK Investigational Site
Amsterdam, 1105 AZ, Netherlands
GSK Investigational Site
Apeldoorn, 7334 DZ, Netherlands
GSK Investigational Site
Blaricum, 1261 AN, Netherlands
GSK Investigational Site
Deventer, 7416 SE, Netherlands
GSK Investigational Site
Dirksland, 3247 BW, Netherlands
GSK Investigational Site
Doetinchem, 7009 BL, Netherlands
GSK Investigational Site
Drachten, 9202 NN, Netherlands
GSK Investigational Site
Eindhoven, 5623 EJ, Netherlands
GSK Investigational Site
Gorinchem, 4204 AA, Netherlands
GSK Investigational Site
Gouda, 2803 HH, Netherlands
GSK Investigational Site
Groningen, 9728 NT, Netherlands
GSK Investigational Site
Hardenberg, 7772 SE, Netherlands
GSK Investigational Site
Harderwijk, 3844 DG, Netherlands
GSK Investigational Site
Heerenveen, 8441 PW, Netherlands
GSK Investigational Site
Heerlen, 6419 PC, Netherlands
GSK Investigational Site
Helmond, 5707 HA, Netherlands
GSK Investigational Site
Hilversum, 1213 XZ, Netherlands
GSK Investigational Site
Hoofddorp, 2134 TM, Netherlands
GSK Investigational Site
Hoorn, 1625 HV, Netherlands
GSK Investigational Site
Nijmegen, 6532 SZ, Netherlands
GSK Investigational Site
Oss, 5342 BT, Netherlands
GSK Investigational Site
Roermond, 6043 CV, Netherlands
GSK Investigational Site
Rotterdam, 3045 PM, Netherlands
GSK Investigational Site
Rotterdam, 3083 AN, Netherlands
GSK Investigational Site
Sittard-geleen, 6162 BG, Netherlands
GSK Investigational Site
Sneek, 8601 ZR, Netherlands
GSK Investigational Site
The Hague, 2597 AX, Netherlands
GSK Investigational Site
Tiel, 4002 WP, Netherlands
GSK Investigational Site
Tilburg, 5042AD, Netherlands
GSK Investigational Site
Veldhoven, 5504 DB, Netherlands
GSK Investigational Site
Venlo, 5912 BL, Netherlands
GSK Investigational Site
Zoetermeer, 2725 NA, Netherlands
GSK Investigational Site
Auckland, 2025, New Zealand
GSK Investigational Site
Auckland, New Zealand
GSK Investigational Site
Christchurch, New Zealand
GSK Investigational Site
Dunedin, New Zealand
GSK Investigational Site
Hamilton, 3204, New Zealand
GSK Investigational Site
Lower Hutt, 6007, New Zealand
GSK Investigational Site
New Plymouth, 4310, New Zealand
GSK Investigational Site
Palmerston North, New Zealand
GSK Investigational Site
Takapuna, Auckland, 0622, New Zealand
GSK Investigational Site
Tauranga, New Zealand
GSK Investigational Site
Whangarei, New Zealand
GSK Investigational Site
San Martín de Porres, Lima region, Lima 31, Peru
GSK Investigational Site
Miraflores, Lima, Lima, Lima 18, Peru
GSK Investigational Site
Callao, Callao 02, Peru
GSK Investigational Site
Lima, Lima 11, Peru
GSK Investigational Site
Lima, Lima 27, Peru
GSK Investigational Site
Lima, Lima 33, Peru
GSK Investigational Site
Lima Cercado, LIMA 01, Peru
GSK Investigational Site
Cebu City, 6000, Philippines
GSK Investigational Site
Davao City, 8000, Philippines
GSK Investigational Site
Manila, 1000, Philippines
GSK Investigational Site
Quezon City, 1100, Philippines
GSK Investigational Site
Quezon City, 1109, Philippines
GSK Investigational Site
Quezon City, 1113, Philippines
GSK Investigational Site
Bialystok, 15-276, Poland
GSK Investigational Site
Bydgoszcz, 85-079, Poland
GSK Investigational Site
Bytom, 41-902, Poland
GSK Investigational Site
Chrzanów, 32-500, Poland
GSK Investigational Site
Gdansk, 80-952, Poland
GSK Investigational Site
Gdynia, 81-423, Poland
GSK Investigational Site
Gdynia, 81-472, Poland
GSK Investigational Site
Gdynia, 81-519, Poland
GSK Investigational Site
Inowrocław, Poland
GSK Investigational Site
Krakow, 31-121, Poland
GSK Investigational Site
Krakow, 31-202, Poland
GSK Investigational Site
Lodz, 91-347, Poland
GSK Investigational Site
Lubin, 59-300, Poland
GSK Investigational Site
Mielec, 39-300, Poland
GSK Investigational Site
Opole, 45-418, Poland
GSK Investigational Site
Oława, 55-200, Poland
GSK Investigational Site
Radom, 26-617, Poland
GSK Investigational Site
Skierniewice, 96-100, Poland
GSK Investigational Site
Tarnów, 33-100, Poland
GSK Investigational Site
Torun, 87-100, Poland
GSK Investigational Site
Tychy, 43-100, Poland
GSK Investigational Site
Warsaw, 00-685, Poland
GSK Investigational Site
Warsaw, 02-507, Poland
GSK Investigational Site
Warsaw, 02-637, Poland
GSK Investigational Site
Warsaw, 04-073, Poland
GSK Investigational Site
Wałbrzych, 58-309, Poland
GSK Investigational Site
Wroclaw, 50-349, Poland
GSK Investigational Site
Wroclaw, 50-367, Poland
GSK Investigational Site
Wroclaw, 51-124, Poland
GSK Investigational Site
Włocławek, 87-800, Poland
GSK Investigational Site
Zamość, 22-400, Poland
GSK Investigational Site
Zielona Góra, 65-046, Poland
GSK Investigational Site
Baia Mare, 430123, Romania
GSK Investigational Site
Brasov, 500326, Romania
GSK Investigational Site
Brăila, 810249, Romania
GSK Investigational Site
Bucharest, 011461, Romania
GSK Investigational Site
Bucharest, 011794, Romania
GSK Investigational Site
Bucharest, 014461, Romania
GSK Investigational Site
Bucharest, 022328, Romania
GSK Investigational Site
Bucharest, 041915, Romania
GSK Investigational Site
Bucharest, 050098, Romania
GSK Investigational Site
Cluj-Napoca, 400001, Romania
GSK Investigational Site
Constanța, 900591, Romania
GSK Investigational Site
Craiova, 200642, Romania
GSK Investigational Site
Iași, 700503, Romania
GSK Investigational Site
Târgu Mureş, 540136, Romania
GSK Investigational Site
Barnaul, 656024, Russia
GSK Investigational Site
Gatchina, 188300, Russia
GSK Investigational Site
Kemerovo, 650002, Russia
GSK Investigational Site
Kemerovo, 650036, Russia
GSK Investigational Site
Krasnoyarsk, 660097, Russia
GSK Investigational Site
Moscow, 105187, Russia
GSK Investigational Site
Moscow, 111020, Russia
GSK Investigational Site
Moscow, 111539, Russia
GSK Investigational Site
Moscow, 117292, Russia
GSK Investigational Site
Moscow, 119620, Russia
GSK Investigational Site
Moscow, 119991, Russia
GSK Investigational Site
Moscow, 121 309, Russia
GSK Investigational Site
Moscow, 121552, Russia
GSK Investigational Site
Moscow, 127018, Russia
GSK Investigational Site
Moscow, 127473, Russia
GSK Investigational Site
Nizhny Novgorod, 603035, Russia
GSK Investigational Site
Nizhny Novgorod, 603076, Russia
GSK Investigational Site
Novosibirsk, 630008, Russia
GSK Investigational Site
Novosibirsk, 630047, Russia
GSK Investigational Site
Orenburg, 460040, Russia
GSK Investigational Site
Saint Petersburg, 190000, Russia
GSK Investigational Site
Saint Petersburg, 192242, Russia
GSK Investigational Site
Saint Petersburg, 193079, Russia
GSK Investigational Site
Saint Petersburg, 193312, Russia
GSK Investigational Site
Saint Petersburg, 195067, Russia
GSK Investigational Site
Saint Petersburg, 196247, Russia
GSK Investigational Site
Saint Petersburg, 196601, Russia
GSK Investigational Site
Saint Petersburg, 198013, Russia
GSK Investigational Site
Saint Petersburg, 198205, Russia
GSK Investigational Site
Saint Petersburg, 199106, Russia
GSK Investigational Site
Samara, 443070, Russia
GSK Investigational Site
Saratov, 410028, Russia
GSK Investigational Site
Saratov, 410054, Russia
GSK Investigational Site
St'Petersburg, 194156, Russia
GSK Investigational Site
Tomsk, 643012, Russia
GSK Investigational Site
Tyumen, 625023, Russia
GSK Investigational Site
Tyumen, 625026, Russia
GSK Investigational Site
Yaroslavl, 150003, Russia
GSK Investigational Site
Yekaterinburg, 620039, Russia
GSK Investigational Site
Yekaterinburg, 620109, Russia
GSK Investigational Site
Bratislava, 813 69, Slovakia
GSK Investigational Site
Bratislava, 826 06, Slovakia
GSK Investigational Site
Bratislava, 833 05, Slovakia
GSK Investigational Site
Bratislava, 833 48, Slovakia
GSK Investigational Site
Košice, 040 22, Slovakia
GSK Investigational Site
Nitra, 949 01, Slovakia
GSK Investigational Site
Nitra, 950 01, Slovakia
GSK Investigational Site
Nové Zámky, 940 52, Slovakia
GSK Investigational Site
Bloemfontein, Free State, 9301, South Africa
GSK Investigational Site
Alberton, Gauteng, 1449, South Africa
GSK Investigational Site
Johannesburg, Gauteng, 2000, South Africa
GSK Investigational Site
Pretoria, Gauteng, 0001, South Africa
GSK Investigational Site
Pretoria, Gauteng, 0132, South Africa
GSK Investigational Site
Durban, KwaZulu-Natal, 4001, South Africa
GSK Investigational Site
Durban, KwaZulu-Natal, 4052, South Africa
GSK Investigational Site
Cape Town, Western Province, 7500, South Africa
GSK Investigational Site
Cape Town, Western Province, 7530, South Africa
GSK Investigational Site
Panorama, Western Province, 7500, South Africa
GSK Investigational Site
Goodwood, 7460, South Africa
GSK Investigational Site
Kempton Park, 1619, South Africa
GSK Investigational Site
Paarl, 7646, South Africa
GSK Investigational Site
Parktown West, 2193, South Africa
GSK Investigational Site
Parow, 7505, South Africa
GSK Investigational Site
Pretoria, 0002, South Africa
GSK Investigational Site
Pretoria, 0041, South Africa
GSK Investigational Site
Somerset West, 7130, South Africa
GSK Investigational Site
Worcester, 6850, South Africa
GSK Investigational Site
Daegu, 700-721, South Korea
GSK Investigational Site
Daejeon, 301721, South Korea
GSK Investigational Site
Gangnam-gu, Seoul, 135-710, South Korea
GSK Investigational Site
Gwangju, 501-757, South Korea
GSK Investigational Site
Kangwon-do, 220-701, South Korea
GSK Investigational Site
Pusan, 602-739, South Korea
GSK Investigational Site
Seoul, 110-744, South Korea
GSK Investigational Site
Seoul, 120-752, South Korea
GSK Investigational Site
Seoul, 137-701, South Korea
GSK Investigational Site
Seoul, 138-736, South Korea
GSK Investigational Site
Alicante, 03010, Spain
GSK Investigational Site
Barcelona, 08035, Spain
GSK Investigational Site
León, 24071, Spain
GSK Investigational Site
Lleida, 25198, Spain
GSK Investigational Site
Madrid, 28006, Spain
GSK Investigational Site
Madrid, 28046, Spain
GSK Investigational Site
Málaga, 29010, Spain
GSK Investigational Site
Oviedo, 33006, Spain
GSK Investigational Site
San Juan/Alicante, 03550, Spain
GSK Investigational Site
San Sebastián, 20014, Spain
GSK Investigational Site
San Sebastián de Los Reyes/Madrid, Spain
GSK Investigational Site
Seville, 41009, Spain
GSK Investigational Site
Valencia, 46014, Spain
GSK Investigational Site
Vigo/Pontevedra, 36200, Spain
GSK Investigational Site
Gothenburg, SE-413 45, Sweden
GSK Investigational Site
Gothenburg, SE-41685, Sweden
GSK Investigational Site
Gothenburg, SE-43180, Sweden
GSK Investigational Site
Hässleholm, SE-28125, Sweden
GSK Investigational Site
Jönköping, SE-551 85, Sweden
GSK Investigational Site
Örebro, SE-70185, Sweden
GSK Investigational Site
Östersund, SE-831 83, Sweden
GSK Investigational Site
Stockholm, SE-11883, Sweden
GSK Investigational Site
Västerås, SE-721 89, Sweden
GSK Investigational Site
Kaohsiung City, 807, Taiwan
GSK Investigational Site
Kaohsiung City, 833, Taiwan
GSK Investigational Site
Taipei, 111, Taiwan
GSK Investigational Site
Taipei, 112, Taiwan
GSK Investigational Site
Taipei, 220, Taiwan
GSK Investigational Site
Yung Kang City, 71044, Taiwan
GSK Investigational Site
Bangkok, 10400, Thailand
GSK Investigational Site
Bangkoknoi, 10700, Thailand
GSK Investigational Site
Chiang Mai, 50200, Thailand
GSK Investigational Site
Khon Kaen, Muang, 40002, Thailand
GSK Investigational Site
Nakhon Ratchasima, 30000, Thailand
GSK Investigational Site
Pathum Thani, 12120, Thailand
GSK Investigational Site
Ankara, 06500, Turkey (Türkiye)
GSK Investigational Site
Erzurum, 25240, Turkey (Türkiye)
GSK Investigational Site
Eskişehir, 26480, Turkey (Türkiye)
GSK Investigational Site
Izmir, 35100, Turkey (Türkiye)
GSK Investigational Site
Izmir, 35340, Turkey (Türkiye)
GSK Investigational Site
Izmir, 35360, Turkey (Türkiye)
GSK Investigational Site
Dnipropetrovsk, 49006, Ukraine
GSK Investigational Site
Donetsk, 83114, Ukraine
GSK Investigational Site
Kharkiv, 61002, Ukraine
GSK Investigational Site
Kharkiv, 61018, Ukraine
GSK Investigational Site
Kharkiv, 61039, Ukraine
GSK Investigational Site
Kharkiv, 61176, Ukraine
GSK Investigational Site
Kyiv, 01601, Ukraine
GSK Investigational Site
Kyiv, 02091, Ukraine
GSK Investigational Site
Kyiv, 02660, Ukraine
GSK Investigational Site
Kyiv, 03049, Ukraine
GSK Investigational Site
Kyiv, 03680, Ukraine
GSK Investigational Site
Kyiv, 3115, Ukraine
GSK Investigational Site
Luhansk, 91045, Ukraine
GSK Investigational Site
Lutsk, 43024, Ukraine
GSK Investigational Site
Mykolaiv, 54033, Ukraine
GSK Investigational Site
Odesa, 65014, Ukraine
GSK Investigational Site
Simferopol, 95026, Ukraine
GSK Investigational Site
Vinnytsia, 21018, Ukraine
GSK Investigational Site
Vinnytsia, 21029, Ukraine
GSK Investigational Site
Zaporizhzhya, 69000, Ukraine
GSK Investigational Site
Exeter, Devon, EX2 5DW, United Kingdom
GSK Investigational Site
Torquay, Devon, TQ2 7AA, United Kingdom
GSK Investigational Site
Airdrie, Lanarkshire, ML6 0JS, United Kingdom
GSK Investigational Site
Harrow, Middlesex, HA1 3UJ, United Kingdom
GSK Investigational Site
Northampton, Northamptonshire, NN1 5BD, United Kingdom
GSK Investigational Site
Nottingham, Nottinghamshire, NG5 1PB, United Kingdom
GSK Investigational Site
Chertsey, Surrey, KT16 0PZ, United Kingdom
GSK Investigational Site
Coventry, West Midlands, CV2 2DX, United Kingdom
GSK Investigational Site
Antrim, BT41 2RL, United Kingdom
GSK Investigational Site
Chichester, PO19 6SE, United Kingdom
GSK Investigational Site
East Kilbride, G75 8RG, United Kingdom
GSK Investigational Site
Hertfordshire, United Kingdom
GSK Investigational Site
Liverpool, L7 8XP, United Kingdom
GSK Investigational Site
Paisley, PA2 9PN, United Kingdom
GSK Investigational Site
Stirling, FK8 2AU, United Kingdom
Related Publications (5)
Correa S, Morrow DA, Braunwald E, Davies RY, Goodrich EL, Murphy SA, Cannon CP, O'Donoghue ML. Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome. J Am Heart Assoc. 2018 Oct 16;7(20):e009077. doi: 10.1161/JAHA.118.009077.
PMID: 30371283DERIVEDBarger LK, Rajaratnam SMW, Cannon CP, Lukas MA, Im K, Goodrich EL, Czeisler CA, O'Donoghue ML. Short Sleep Duration, Obstructive Sleep Apnea, Shiftwork, and the Risk of Adverse Cardiovascular Events in Patients After an Acute Coronary Syndrome. J Am Heart Assoc. 2017 Oct 10;6(10):e006959. doi: 10.1161/JAHA.117.006959.
PMID: 29018021DERIVEDEisen A, Cannon CP, Braunwald E, Steen DL, Zhou J, Goodrich EL, Im K, Dalby AJ, Spinar J, Daga S, Lukas MA, O'Donoghue ML. Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial. J Am Heart Assoc. 2017 Jan 11;6(1):e004332. doi: 10.1161/JAHA.116.004332.
PMID: 28077384DERIVEDO'Donoghue ML, Braunwald E, White HD, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP; SOLID-TIMI 52 Investigators; Steen DL. Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial. JAMA. 2014 Sep 10;312(10):1006-15. doi: 10.1001/jama.2014.11061.
PMID: 25173516DERIVEDO'Donoghue ML, Braunwald E, White HD, Serruys P, Steg PG, Hochman J, Maggioni AP, Bode C, Weaver D, Johnson JL, Cicconetti G, Lukas MA, Tarka E, Cannon CP. Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome. Am Heart J. 2011 Oct;162(4):613-619.e1. doi: 10.1016/j.ahj.2011.07.018. Epub 2011 Sep 15.
PMID: 21982651DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- GSK Response Center
- Organization
- GlaxoSmithKline
Study Officials
- STUDY DIRECTOR
GSK Clinical Trials
GlaxoSmithKline
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 22, 2009
First Posted
October 23, 2009
Study Start
December 1, 2009
Primary Completion
April 1, 2014
Study Completion
April 24, 2014
Last Updated
August 10, 2017
Results First Posted
August 10, 2017
Record last verified: 2017-06
Data Sharing
- IPD Sharing
- Will share
Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site.